TCM last traded at ₹48.00 (2026-10-13). Over the past month the stock moved +2.1%, three months the stock moved -5.3%, year the stock moved -4.5%. Its closing range over 52 weeks is ₹39.22 – ₹74.33, with the latest close 35.4% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1943, TCM Ltd deals in solar panels, healthcare products, and cattle feed products.[1]
Business Overview:[1] TCML is in the business of setting up and commissioning of Solar Power plants, trading of medical diagnostic products, manufacture of cattle feed and real estate business.
In the latest quarter (Jun 2026), TCM reported sales of ₹4.88 crore (+52.0%) and net profit of ₹-1.60 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 4.88 | -0.98 | -20.08 | -1.60 | -2.14 |
| Mar 2026 | 4.92 | -1.16 | -23.58 | -1.63 | -2.21 |
| Dec 2025 | 5.69 | -0.55 | -9.67 | -1.18 | -1.52 |
| Sep 2025 | 5.92 | -0.83 | -14.02 | -0.83 | -1.04 |
| Jun 2025 | 3.21 | -1.96 | -61.06 | -2.35 | -3.00 |
| Mar 2025 | 7.65 | 0.06 | 0.78 | 4.03 | 5.39 |
| Dec 2024 | 6.18 | -0.59 | -9.55 | -0.90 | -1.15 |
| Sep 2024 | 6.90 | -0.59 | -8.55 | -0.63 | -0.76 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +36.9% | -45.3% | -10.9% | -39.2% | -14.2% | -7.9% | -35.7% | +52.0% |
| Operating profit growth | – | -175.6% | – | – | – | – | -2033.3% | – |
| Net profit growth | – | -230.4% | – | – | – | – | -140.4% | – |
| EPS growth | – | -217.3% | – | – | – | – | -141.0% | – |
| OPM % | -8.6% | -9.6% | 0.8% | -61.1% | -14.0% | -9.7% | -23.6% | -20.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), TCM reported sales of ₹19.74 crore (-24.1%) and net profit of ₹-5.99 crore (-527.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 19.74 | -4.51 | -22.85 | -5.99 | -7.77 |
| Mar 2025 | 26.01 | -2.16 | -8.30 | 1.40 | 2.15 |
| Mar 2024 | 32.23 | -2.22 | -6.89 | -2.29 | -2.61 |
| Mar 2023 | 7.35 | -3.66 | -49.80 | -4.27 | -5.35 |
| Mar 2022 | 3.55 | -4.01 | -112.96 | -5.88 | -6.85 |
| Mar 2021 | 4.23 | -0.88 | -20.80 | 0.12 | 0.16 |
| Mar 2020 | 0.92 | -0.83 | -90.22 | 0.30 | 0.40 |
| Mar 2019 | 0.40 | -0.86 | -215.00 | -0.95 | -1.27 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +130.0% | +359.8% | -16.1% | +107.0% | +338.5% | -19.3% | -24.1% |
| Operating profit growth | – | – | – | – | – | – | – |
| Net profit growth | – | -60.0% | -5000.0% | – | – | – | -527.9% |
| EPS growth | – | -60.0% | -4381.3% | – | – | – | -461.4% |
| OPM % | -90.2% | -20.8% | -113.0% | -49.8% | -6.9% | -8.3% | -22.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for TCM.
Get Free AI Stock Analysis FREE →TCM Signs Kalamassery JV MoU; Shares Up 7.1%
TCM Signs Kalamassery JV MoU; Shares Up 7.1%
TCM Limited's Rs 7.92 Crore Solar Project Contract Cancelled by CIAL Infrastructures - scanx.trade
TCM Limited's Rs 7.92 Crore Solar Project Contract Cancelled by CIAL Infrastructures - scanx.trade
TCM shares were last quoted at ₹48.00 (+1.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
TCM has a price-to-earnings (P/E) ratio of -12.76 and a price-to-book (P/B) ratio of 1.86. The industry P/E is 35.59.
The 52-week high of TCM is ₹81.00 and the 52-week low is ₹36.53.
The market capitalisation of TCM is about ₹42.92 crore.
In the latest quarter (Jun 2026), TCM reported sales of ₹4.88 crore (+52.0%) and net profit of ₹-1.60 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, TCM has a 3-year ROE of -7.00%, 3-year profit growth of -18.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 49.51% of TCM.
TCM belongs to the Commodity Chemicals sector.